: Moderna stock pops after cancer-vaccine candidate gets FDA breakthrough designation
Moderna Inc. MRNAand Merck Inc. MRK shares increased in after-hours trading Wednesday after the pharmaceutical companies announced that a cancer-vaccine candidate received the “breakthrough therapy”...